Background: Accurate prediction of the progression of brucellosis is critical for optimizing therapeutic interventions, yet reliable biomarkers for this transition remain elusive. Method: Single-cell RNA sequencing (scRNA-seq) of peripheral blood mononuclear cells (PBMCs) from acute (AC), subacute (SA), and chronic (CH) brucellosis patients identified nine immune subsets. Machine learning models trained on cell-type-specific gene signatures predicted brucellosis progression. Result: Among the evaluated models, the least absolute shrinkage and selection operator showed the best classification performance, achieving an accuracy of 0.98 (95% CI, 0.98–0.99) and an AUC of 0.99 (95% CI, 0.99–1.00) for CD8+ T cells, and an accuracy of 0.96 (95% CI, 0.94–0.97) and an AUC of 0.97 (95% CI, 0.99–1.00) for NK cells. A conserved triphasic transcriptional trajectory (upregulation: healthy to AC; downregulation: AC to SA; partial recovery: SA to CH) in adaptive/innate immune cells implicated interferon signaling. Fourteen core genes ( IFI44L , ISG15 , and MX1 ) formed tightly connected networks (interaction score > 0.7), linking chronic infection to immune dysregulation. Conclusion: We establish the first scRNA-seq-guided predictive framework for brucellosis chronicity, highlighting CD8 + T/NK cell signatures and interferon-driven reprogramming as therapeutic targets.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: